QualityStocksNewsBreaks Archives - Page 982 of 1387

WednesdayNov 20, 2019 12:32 pm

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Present at Upcoming LD Micro Main Event

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, this morning announced that Chief Financial Officer Eli Yoresh and Vice President of Business Development Doron Cohadier will be presenting at the 12th Annual LD Micro Main Event at 2:20 PM ET on Tuesday December 10, 2019. The event is taking place at the Luxe Sunset Boulevard Hotel in Los Angeles and a live webcast of the presentation will be available to the public. Yoresh and Cohadier will also be available for one-on-one meetings on December 10 and 11. To schedule a meeting, contact Miri Segal at msegal@ms-ir.com.…

WednesdayNov 20, 2019 11:36 am

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Secures Contract with Fraunhofer IAPT to Upgrade PrintRite3D

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, this morning announced that it has been awarded a contract by the Fraunhofer Research Institution for Additive Manufacturing Technologies (“IAPT”) to upgrade its current version PrintRite3D system to version 5.1. “Fraunhofer IAPT is an undisputed thought leader, advancing the additive manufacturing industry through the incredible research work it does every day,” Sigma Labs CEO John Rice stated in the news release. “Through the material progress accomplished in our relationship and its utilization of our latest PrintRite3D technology, I'm confident that together we will…

WednesdayNov 20, 2019 10:47 am

QualityStocksNewsBreaks – MCTC Holdings Inc. (MCTC) Expands Research & Development Program

Los Angeles, California-based MCTC Holdings (OTC: MCTC) this morning announced that it is expanding its research and development (“R&D”) program designed to produce polymeric nanoparticles of cannabinol (“CBN”). The expansion aims to create nanoparticles of cannabinoid glycosides, which the company believes will hold considerable commercial viability in the future. MCTC’s research team plans to produce CBN nanoparticles with both immediate and controlled-release properties based on the company’s experience producing cannabidiol (“CBD”) nanoparticles and nanofibers. MCTC also added the creation of nanoparticles of cannabinoid glycosides to its research program. “We are continuing our R&D programs based on three primary goals,” MCTC…

WednesdayNov 20, 2019 10:08 am

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Q3 2019 Results

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, on Tuesday announced its financial results for the quarter ended September 30, 2019. Among the highlights, Endonovo reported a 153% increase in revenues for the three months ended September 30, 2019 to $54,039 and a 293% increase in revenues for the nine months ended September 30, 2019 to $161,720, as compared to the same periods last year. “Although our third-quarter operating results and our revenues failed to meet previously announced projections, the efforts throughout the quarter and first nine-months of this year have been extremely positive considering the…

WednesdayNov 20, 2019 9:26 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Subsidiary Exceeds Revenue Growth Goals in Q3 2019

Direct Solar, a subsidiary of SinglePoint (OTCQB: SING), on Tuesday reported that it continues to exceed revenue growth targets and has been key to improving the company’s financials. Among other highlights, Direct Solar originated contracts totaling $4,965,975 and opened in three new states during the third quarter of 2019. “We have been on an upswing as more people are finding out about Direct Solar and what we bring to the market. From homeowners to developers and commercial building owners, we have a solution. We believe the market for residential alone is around 100 million homes. With the complexity around buying…

TuesdayNov 19, 2019 3:20 pm

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) BIGtoken App Makes Owning, Monetizing Personal Data Possible

Digital-marketing and consumer-data-management technology platform company SRAX (NASDAQ: SRAX) has developed a consumer-managed data marketplace via its BIGtoken platform that enables people to own and earn from their data. An article discussing the company reads, “After being operational for a year, SRAX decided to poll its BIGtoken community regarding its data-privacy awareness. The survey yielded valuable insights into the way consumers view their online presence. For SRAX, one promising result of the survey showed that 62% of its users would allow more advertisements if they were being paid for the data that delivered the ad. Of concern for the company…

TuesdayNov 19, 2019 11:45 am

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Announces Strong Preliminary Calendar 2019 Performance that Exceeds Internal Forecasts

Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today announced preliminary calendar year-to-date revenue performance of $26 million and strengthening gross margins. Per the update, the company expects its recently-acquired hydroponics supply operation to produce approximately $32 million for the calendar year and believes it is well positioned moving into 2020 based on growing revenues and an expanding sector cost advantage. “This business sector is all about robust product sourcing, efficiency in logistics and effective e-commerce programs, not to mention effective placement on Amazon, where we are realizing great success. Our revenue and gross margin…

TuesdayNov 19, 2019 11:31 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO Discusses Corporate, Scientific Milestones in NetworkNewsAudio Interview

Predictive Oncology (NASDAQ: POAI), an artificial intelligence (“AI”) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through innovative data-driven products and services, this morning announced the broadcast of a NetworkNewsAudio (“NNA”) interview with Stuart Smith of NetworkNewsWire (“NNW”). Predictive Oncology CEO Dr. Carl Schwartz joined Smith to discuss several corporate and scientific milestones that have been achieved by the company in 2019, as well as POAI’s strategy moving forward. “Predictive Oncology and its subsidiaries, in collaboration with key players in the pharmaceutical, diagnostic and biotech industries, are finding success in…

TuesdayNov 19, 2019 11:19 am

QualityStocksNewsBreaks – Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) CEO Discusses Production, Talent and Expansion in Exclusive Audio Interview

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF), a producer of high-quality feature films and episodic television with international appeal, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), a NetworkNewsWire (“NNW”) solution. In the interview, Wonderfilm Media CEO Kirk Shaw joins NNW’s Stuart Smith to discuss the company’s business model in producing quality theatrical releases and entertainment content for an expanding array of streaming services. Shaw briefly highlights Wonderfilm’s most recent releases, which include “The Fanatic,” starring John Travolta, “Tammy’s Always Dying,” starring Felicity Huffman, which premiered at the Toronto Film Festival, and action-packed thriller “Primal,” starring Nicolas Cage,…

TuesdayNov 19, 2019 10:59 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Reports Preclinical Data Showing Positive Results for Treatment of Resistant Metastatic Lung Cancers

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that its collaborators from The University of Texas MD Anderson Cancer Center (“MD Anderson”) presented positive preclinical data at the American Association of Cancer Research Tumor Immunology and Immunotherapy Meeting 2019. According to the update, the data shows positive results for the combination of TUSC2 immunogene therapy with an anti-PD1 antibody, pembrolizumab, and for the combination of TUSC2 immunogene therapy, pembrolizumab, and chemotherapy for the treatment of some of the most resistant metastatic lung cancers, including the KRAS and LKB1 mutations. “These data not only further support existing preclinical data…

Site Search

Company Search

Category: QualityStocksNewsBreaks